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INTRODUCTION:THE NORMAL BREAST
Although breast tissue is present in both sexes, it is
the female who undergoes radical changes starting with
puberty, in pregnancies, and then through menopause, creat-
ing tremendous stress on normal breasts.Breasts consist
of glandular tissue for milk production and secretion, as
well as fibrous, adipose, lymphatic, circulatory, and nerv-
ous tissues.Most of the breast's bulk, except during
lactation, is composed of adipose tissue.Glandular tissue
forms the lobes and lobules which terminate into the alve-
oli and lactiferous ducts required for milk production
(Warwick, 1973) .
The breasts are controlled by the various reproductive
hormones, with special emphasis on prolactin, estrogen, and
progesterone.Normally, during the reproductive cycling, a
female undergoes monthly changes in breast tissue size.
However, normal breasts should not experience pain, lumps,
or discharge (Berkow & Fletcher, 1987).REVIEW OF LITERATURE
Breast Cancer
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Until 1987, breast cancer was the leading cause of
death in women, but currently it has been replaced by lung
cancer as the number one leading cause of death among
women.Breast cancer rates are increasing for women 55
years of age and older.Rates of developing breast cancer
appear to be decreasing slightly in women under the age of
55 years (U.S. Department of Health and Human Services,
1988).The American College of Physicians claims that only
20 percent of breast malignancies occur in women under 50
years of age.Furthermore, only 0.2 percent of women
develop breast cancer before the age of 25 (Haagensen,
Bodian,& Haagensen, 1981).Post-menopausal women appear
to be at highest risk for breast cancer (Berkow & Fletcher,
1987).Pre-menopausal women with functioning estrogen-
progesterone hormonal cycles (see following chapter), a
causal factor in premenstrual syndrome, were selected to be
included in this pilot study.The purpose of this study
was to evaluate premenstrual syndrome as a risk-factor to
the onset of breast cancer.Review of the current liter-
ature has indicated that controversy still exists about the
role of reproductive hormones with respect to breast cancer3
(Winfield & Page, 1988).Pre-menopausal women with a
recent history of breast cancer were necessarily considered
due to potential bias since past premenstrual and menstrual
patterns after menopause onset could alter individual
responses.
Common Types of Breast Cancer
Cancer In Situ
Cancers in situ are tumors, or masses, discovered at
their original site of development.Cancers in situ are
self-contained tumors which have not spread or metastasized
into surrounding tissues, at the time of definitive diagno-
sis.Prognosis is better with cancers in situ than with
invasive types of cancers.Most likely invasive cancer
masses are not found at the primary site, but as a secon-
dary metastasis from another area of the body (Berkow &
Fletcher, 1987).Cancers can present with smooth margins,
as in a benign disease such as fibrocystic disease.Quite
often within the breast, small, well-defined, smooth masses
with radioluscent halo of fat on these grams are indicative
of benign tumors.In contrast, lesions with irregular
contours and spiculated margins are the most common indica-
tors of cancer (Winfield & Page, 1988).
Ductal cancers in situ are frequently found as micro-
calcifications (Winfield & Page, 1988).These are impor-
tant diagnostic aids since the presence of calcifications4
indicates cellular necrosis causing calcification of those
dead cells in the hypoxic centers of tumor masses.Yet, in
20 percent of the cases where calcifications are detected,
these calcifications are present without any defined tumor
(Mack, 1990) .
Paget's disease affects the nipple and is associated
with breast cancer.This disease characteristically pre-
sents as a reddened, crusty appearing nipple.An important
clinical indicator of breast cancer, Paget's disease is
usually invasive, a deep tumor mass sending Paget's cells
up the tracts to the nipple.This disease is often associ-
ated with invasive masses.The deep, impalpable nature of
the tumors causes a lengthy time before they can be diag-
nosed, allowing the tumors to grow (Berkow & Fletcher,
1987; Haagensen et al., 1983; Winfield & Page, 1988).
Lobular cancer in situ, is a slow-growing, generally
painless mass involving the lobular units, the smaller
units of the breast lobes that drain into the lactiferous
ducts of the breasts.These cancers are generally hard to
find in their early stages (Winfield & Page, 1988).
Invasive Cancers
From 60 to 70 percent of all breast cancers are inva-
sive.These cancer cells are characterized by spreading
freely throughout the tissue, rather than forming a self-
contained tumor in situ (Agnew et al., 1965).Many lesions5
have extensions of tissue beyond their basement, or founda-
tion membrane.These tumors are not well-defined masses
such as in situ forms of cancer.Invasive cancers are
highly mitotic, rapid growing, and present the poorest
prognosis.The cells of these cancers are so atypical that
there is little concurrence as to their origin, other than
categorization as invasive breast carcinoma, identified by
the location in the breast (Winfield & Page, 1988).
There are some special types of invasive carcinomas
that can be identified by their patterns on presentation to
pathology.For example, mucinous cancers are little is-
lands of cancer cells in pools of mucin, the main component
of mucus.Medullary cancer can appear as smooth and
rounded on diagnostic imaging, which could be misdiagnosed
as a benign lesion.On dissection, large and irregular
cancerous cells can be found within the tumor bathed in
lymph and plasmacyte cells (Winfield & Page, 1988).
Infiltrating lobular cancers are diffuse, without a
palpable mass, making them almost impossible to identify
except by examining the breast for distortions and physical
asymmetry (Winfield et al., 1988).Inflammatory cancer
presents with a warm, erythematous, edematous, painful
breast due to lymphatic involvement and is generally char-
acterized by rapid tumor growth (Berkow & Fletcher, 1987).
Rare malignant tumors account for 5 percent of all
breast cancers.Their compositions are of all types of6
mixed cells, including sarcomas originating from anywhere
within the body (Winfield & Page, 1988).
Recent research reported by the Harvard Medical School
involved the examination of metastatic cancer by counting
new microblood vessel growth in excised tumors.Not all
tumors are capable of sending out tumor metastases, but in
certain forms of invasive cancers there is a biologic proc-
ess known as angiogenesis.New blood vessels develop in
these tumors that can be used for identification of some
virulent forms of cancers.Scientists indicate a 1.6 to
10.0 risk factor for a metastatic condition in each group
of new vessels counted within the tumor ("Capillaries iden-
tify spreadable cancers," 1991).
Risks for Breast Cancer
Most precipitating factors for breast cancer are still
largely unknown. Women are at highest risk for breast can-
cer.Pre-menopausal women between the ages of 35 to 39
years develop breast cancer at a rate of 572 times more
often than in men.This figure shrinks to 34 times after
the age of 85 years (Donegan, 1991).
Higher breast cancer incidence has been attributed to
white women of higher socioeconomic classes, including
women living in North America or northern Europe. Unmar-
ried women, nulliparous (women without prior history of a
viable pregnancy), with early onset menses and late menar-7
che, and familial histories of the disease are also at risk
(Kelsey & Gammon, 1991). However, in the United States,
young premenopausal black women incident rates increased by
40 percent between 1947 to 1981.The rate for young white
women showed a 13.7 percent increase over the same period
of time (Krieger, 1990).Part of these apparent rate
changes may have been affected by factors such as accurate
reporting or access to health care.Jewish women and nuns
appear to have a higher risk for breast cancer.Con-
versely, women from Asia and Africa, Japan, Mexican-
Americans, and American Indians all appear to be at lower
risk (Kelsey & Gammon, 1991).
Familial history with primary relatives, including
mothers and/or sisters with a premenopausal history of
breast cancer, translates to an increased probability of
earlier onset breast cancer for the patient, prior to age
40, and to a greater risk of bilateral breast cancer
(Anderson, 1992; Lynch & Watson, 1990; Mettlin, Croghan,
Natarajan,& Lane, 1990; Roseman, Straus,& Shorey, 1990).
These findings are consistent with many published studies
of the effects of first-degree familial risk, shown in
areas of high and low breast cancer incidence areas geo-
graphically, and are estimated to account for over 10 per-
cent of the breast cancer cases in women under the age of
45 years (Parazzini, La Vecchia, Negri, Francechi,& Boc-
ciolone, 1992).Parazzini et al. also raised the question
of which mechanisms are at play concerning mother and/or8
sister breast cancer risks.These findings were in confor-
mance with those previously established by Mettlin et al.
in 1990.Both studies questioned whether breast cancer in
young women could be an inherited tendency, or an inherited
susceptibility to certain risk factors, including environ-
mental risk factors.This would include, for instance,
women exposed to the same environmental effect living in
close proximity.
The area of genetic research has been focused upon re-
ports specific to the premenopausal breast cancer-heredity
link.Researchers have divided cancer into two categories,
familial-linked breast cancers and wild, or sporadically
induced, cancers (Anderson, 1992). In the familial cate-
gory, there have been four inherited types of breast cancer
associated with early onset, premenopausal, and bilateral
inclusion.
The Li-Fraumeni syndrome, thought to be associated
with breast cancers in women under 35 years of age, has
been suspect in other forms of tumors within families,
especially sarcomas and brain tumors.The Li-Fraumeni
syndrome has been linked to a dominant, inherited gene
mutation found on the p53 gene of the 17th chromosome
(Anderson, 1992; Barnes et al., 1992; Skolnick & Cannon-
Albright, 1992). Cowden disease is a rarer form of inher-
ited breast cancer.It has been reported that 90 percent
of the female carriers have breast tumors and that approxi-
mately 50 percent of those women develop breast cancer9
(Anderson, 1992).However, most commonly breast cancer
develops as an in situ disease associated with a close
relative also diagnosed with breast cancer, also known as
the familial-link risk factor.The fourth type of inher-
ited tumor, lined by studies to either the 8th or the 17th
chromosome, but as yet unconfirmed, is the type of cancer
associated with breast cancer and ovarian cancer (Anderson,
1992; Lynch & Watson, 1990).
Breast cancer among patients without any close rela-
tives who have experienced the disease has been undergoing
greater scrutiny lately.Anderson (1992) theorizes genetic
mutations cause a tumor-suppressing gene to cease function-
ing, allowing abnormal cells to proliferate.Specifically,
the p53 tumor-suppressor gene on the 17th chromosome has
been isolated.This gene has been associated with a ge-
netic predisposition to some forms of hereditary breast
cancers (Levine, 1992; Malkin et al., 1992; Shields et al.,
1991; Skolnick & Cannon-Albright, 1992; Toguchida et al.,
1992).Through these mutated p53 genes, mutated proteins
are produced that accumulate within the tumor cell in
larger amounts than their normal counterparts.These mu-
tated proteins encourage the cells to grow more efficiently
(Levine, 1992).
In addition, studies have supported long-term, low
dosage ionizing radiation as used in chest x-rays and fluo-
roscopy, and the radiation in massive exposures such as the
atomic blasts on Japan, in direct relation to the increase10
of breast cancer (Donegan, 1991; Kelsey & Gammon, 1991;
Shields et al., 1991).
Research has even suggested nitrogen dioxide, a compo-
nent in smog, as a possible influence on breast cancer
promotion.Nitrogen dioxide impairs the ability of killer
T-cells to attack any tumor cells circulating in blood
vessels after breaking off the primary tumor site.This
impairment of the T-cells enhances metastases (Fackelman,
1990) .
Pesticides constitute another area of environmental
research in their potential for promoting breast cancers
(Falck, Ricci, Wolff, Godbold,& Deckers, 1992) .Unfortu-
nately, the study samples considered were too small to
conclusively correlate the exposure of certain pesticides
to breast cancer.However, increased concentrations of
certain pesticides were found in the tumor samples, but the
researchers were unable to determine if the accumulations
were as a result of the disease or were a causal factor.
High fat diets, in which fats constitute more than 30
percent of total daily intake, have been receiving tremen-
dous attention (Cohen, 1987).The associations have been
weak, however, whereas possible confounders have been high.
One study found that fatty foods directly affect estrogen
levels (Raloff, 1990).The United States, Britain, and the
Netherlands have high fat diets and the highest breast
cancer rates.Japan, Singapore, and Romania consume low
fat diets and show from 1/6 to 1/2 the breast cancer rate11
of the United States (Wallis, 1991).Migration studies
show breast cancer incidence rises with diet changes to a
higher fat content.Breast cancer has risen 58 percent in
a five-year study of Japanese women as they westernize and
consume more fat (Cohen, 1987; Kelsey & Gammon, 1991).In
recent studies, higher than normal HDL levels have been
indicated as a factor in the increase of the risk of breast
cancer in women.Higher HDLs reduce the risk of cardiovas-
cular disease, but may stimulate growth of tumor cells in
breast cancer (Willett et al., 1991).
Alcohol consumption of 5g or more per day has been im-
plicated in breast cancer studies.However, flawed study
designs have begged the question of the accuracy of self-
reported drinking habits and the environments in which
subjects consumed their drinks, such as smoke-filled tav-
erns (Schatzkin et al., 1987; Willett et al., 1987).
Studies show a weak positive link between cigarette smoking
and breast cancer, including passive smoking (Palmer et
al., 1991; Wells, 1991) .
Nulliparity, another suspected risk factor, has been
theorized to be due to long uninterrupted blood levels of
estrogen, especially if combined with early onset of menses
(Yoo et al., 1992).Conversely, bilateral oophorectomy
early in the premenopausal stage decreases the risk of
breast cancer development (Kelsey & Gammon, 1991).Reports
have been published to the effect that prolonged breast
feeding, from seven to nine months, may also protect12
against breast cancer (Yoo et al, 1992).However, the
hormonal influence on breast cancer remains a matter of
dispute among a number of researchers (Donlin-Shore, 1991).
Support for hormonally-induced breast cancer remains strong
due to observations which have demonstrated reduced breast
cancer risk after removal of both ovaries, and by cancer
growth stimulation in the presence of estrogen.These
associations, however, may have been confounded by such
factors as tissue changes, immunological changes, environ-
mental influences, or early detection.
The issue of tumor receptors is another aspect of the
hormone debate.Breast cancer tumors without estrogen
uptake are known as negative estrogen receptors.When
compared to estrogen containing tumors, negative estrogen
tumors are larger and are more unstable due to increased
proliferation ability.Compared to estrogen positive re-
ceptor tumors, negative estrogen tumor breast cancer has
evidenced decreased remission periods and is characterized
by a decreased survivor rate (Stanford & Greenberg, 1989).
An association between reproductive hormones, including
exogenous estrogen and breast cancer, has yet to be proven
(Rich, Hager,& Furmanski, 1983; Winfield & Page, 1988).
Amidst the controversy of breast cancer risk, and hor-
monal influences on that risk, are two recently reported
studies.One study conducted in northern Italy looked at
menstrual and reproductive factors concerning familially-
related breast cancer (Parazzini et al., 1992).Reproduc-13
tive factors compared were parity, abortions, age at first
birth, ages at menarche and menopause, and lifetime men-
strual patterns.The study was conducted over seven years,
between 1983 and 1990, selecting approximately 5,000 eligi-
ble subjects for a case-control study.Each subject was
interviewed in person.Roughly one-third of the subjects
were under the age of 45 years.Unfortunately, the results
were not reported by age, only by reproductive patterns and
certain socioeconomic classes.The researchers concluded
there was no discernible risk to familial breast cancer
owing to reproductive and hormonal influences.
The second study was conducted in the then United So-
viet Socialist Republic among three ethnic groups, Moldavi-
ans, Ukrainians, and Russians, comparing reproductive risks
with respect to breast cancer (Pikhut & Levshin, 1988).
The reproductive factors considered were menstrual pat-
terns, age of onset and cessation of menstruation, sexual
activity, parity patterns and ages at first and last birth,
lactation, and premenstrual syndrome.In this case-control
study, 1,175 women were interviewed by a single inter-
viewer.Problems with bias were acknowledged when compar-
ing three different ethnic groups and their differences in
lifestyles, diets, and social patterns.Potential bias
could have been addressed by the use of a single inter-
viewer during the data collection stage.The tables were
not stratified by age, nor did the authors identify what
methods they used to analyze their data.The confounding14
factor of family history specific to reproductive cancer
was not addressed within these ethnic groups.How these
subjects were chosen was not indicated, other than indicat-
ing their breast cancer status.This study found a risk of
breast cancer associated with premenstrual syndrome, OR =
2.4 for urban Moldavians, 2.6 for rural Moldavians, 8.7 for
urban Ukranians, 3.3 for urban Russians, and 13.6 for rural
Russians.For these figures, the level of confidence was
not reported.
In conclusion, continuing research has been indicated
in all areas of breast cancer research, with chromosomal
and genetic involvement appearing to be the most promising
areas of inquiry.PILOT STUDY OF THE RELATION OF PREMENSTRUAL
SYNDROME TO BREAST CANCER
Introduction
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Breast cancer, while relatively rare in premenopausal
women, is the second leading cause of cancer death in women
in the United States (Kelsey & Gammon, 1991). Hormonal
influences relating to breast cancer risk remain unproven
since testing for the various circulating hormones have not
been adequate and are very costly (Stanford & Greenberg,
1989) .
Premenstrual syndrome (PMS) remains a controversial
issue among many factions of the health community
(Rossignol & Phillips, 1992)(Appendix A).Studies of
potential contributors which exacerbate PMS compose an
extensive scientific literature (Harlow & Matanoski, 1991),
and exercise an effect upon the medical community's atti-
tudes and treatment preferences.While the various sympto-
matology comprising this syndrome has been investigated
extensively, few reports have examined the relationship of
PMS to the occurrence of reproductive cancers such as
breast cancer (Boyle, Berkowitz,& Kelsey, 1987).Prior to
the present study, only one other investigation studied PMS
in relation to breast cancer (Pikhut & Levshin, 1988).16
Undertaken in Russia, the investigators studied reproduc-
tive function, and in addition found a positive link be-
tween PMS and the development of breast cancer.This study
found an increased risk of breast cancer associated with
premenstrual syndrome, reporting OR ratios of 2.4 for urban
Moldavians, an 2.6 among rural Moldavians, 8.7 for urban
Ukranians, 3.3 for urban Russians, and 13.6 for rural Rus-
sians.
The purpose of this pilot study was to survey pre-
menopausal women recently diagnosed with breast cancer.
These women were compared to three different control groups
to determine if there was any excess risk of breast cancer
associated with PMS.
Research Methods
This pilot study, conducted at Oregon State University
in Corvallis, Oregon, selected 66 eligible women from two
Oregon clinics specializing in breast diseases.One clinic
was located in a semi-rural setting.The other office was
located in a suburb of a larger metropolitan area.Both
clinics were operated by the same physician.Each subject
was selected based on the following criteria:Women who
had experienced a recent, positive diagnosis of breast
cancer before reaching menopause, who were currently men-
struating or within a year of cessation due to chemother-17
apy, who were between the ages of 20 to 50 years, and who
had no history of a complete hysterectomy.
Each subject was mailed a questionnaire requesting
participation with a cover letter detailing the voluntary
nature of the inquiry and assuring the anonymity of their
responses (Appendix B).The questionnaire probed for pre-
menstrual svmptomatology, menstrual discomforts, for surgi-
cal procedures, medications, term pregnancies, and for
general information, including age, height, and weight.
The premenstrual symptoms listed on the form focused common
complaints.These complaints included headache, bloating
and weight gain, acne, depression, irritability, tiredness,
cravings for salty or sweet foods, binge eating, and breast
swelling and tenderness.An "other symptoms" category was
also included.The symptoms were ranked by the participant
on the basis of mild, moderate, or severe.To differenti-
ate premenstrual from menstrual symptoms, a question was
included asking the number of days before menses onset that
premenstrual symptoms occurred.
Of the 66 total surveys mailed, 57 of the women re-
sponded by returning the questionnaires (i.e., 86% rate of
response).Three mailings were duplications since some
patients had been seen at both clinics.Nine of the sub-
jects chose not to participate in the study.Three surveys
were subsequently eliminated from the study due to self-
disclosure of complete hysterectomies with the removal of
both ovaries and fallopian tubes.18
The control group data were selected from two previous
studies conducted at Oregon State University between 1985
and 1990 by Rossignol and Bonnlander (1990, 1991).Sub-
jects for these studies were chosen based upon the same
selection criteria as the breast cancer patients, with the
exception that these subjects did not have breast cancer.
The data consisted of 193 routine medical exam patients
from seven local obstetrical/gynecological offices, 559
graduate students from O.S.U., and 51 nursing students in
their first year of nursing school.Similar to the sub-
jects of the present study, the controls were either mailed
or personally handed a questionnaire.The response rate
varied among the controls.The graduate student study, in
1988, had a 61 percent response rate:Of 1,419 eligible
students receiving the questionnaire, 869 were returned
after two mailings.Of those responses, 559 women between
the ages of 24 and 53 years met the study requirements,
based on active, regular menstruation.
The subjects recruited from physician offices were
given questionnaires by their physicians.The unpublished
results of the study (Rossignol « Bonnlander, 1991) states
that the manner in which the patients were given these
surveys varied, depending on the administering physician.
Some physicians made sure that each eligible woman received
one while others did not.Response bias was assessed by
comparing the data obtained from the doctor who gave all
the eligible women questionnaires to those of physicians19
using variable systems, finding no difference among the
responses.Of 284 eligible women, the results from 91
women seeking specific medical treatment were not consid-
ered in the present survey since the existence of breast
cancer was difficult to ascertain from the data available.
Only the 193 women visiting physicians for routine physical
exams were included for purposes of data analysis.
The survey was given to each nursing student by an in-
structor, completed by the student, and then returned to
the instructor during class (Rossignol & Bonnlander, 1990).
The exact response rate is unknown, but almost the entire
class was reported to have submitted completed forms to the
instructor (n=73).Of the total number of forms submitted,
22 were eliminated from data analysis because they failed
to meet the study admission criteria.
The survey form used for the cases was almost identi-
cal to the form used for the controls.The only difference
between the questionnaires pertained to a question included
for the control groups about major areas of concentration
in their college studies, if they were among the two stu-
dent groups, or the reason for their visit if they were a
medical patient.A question referring to the participant's
willingness to be interviewed in person was deleted on the
breast cancer patients' surveys.A question was added to
the case group questionnaire inquiring whether the respon-
dents had changed their dietary habits since their cancer
had been diagnosed.In this pilot study, to enhance compa-20
rability and prevent bias, every effort was made to closely
follow the exact format for data collection used in each of
the prior studies (Rossignol & Bonnlander, 1990, 1991).
Once the data were collected, a computer-generated
statistical analysis program, the Statistical Package for
the Social Sciences (SPSS/PC+), was used to analyze the
information.Each of the three control groups was compared
to the breast cancer case group to examine any potential
risk PMS may present in relation to breast cancer.The
exposure odds ratios were estimated, and chi-square analy-
sis was used to estimate variances (Hennekens & Buring,
1987).Each group was then stratified by age to ascertain
possible effect modification by age.The crude exposure
odds ratios within each control group were compared to the
age-stratified pooled exposure odds ratios for further
examination of potential age confounding.
Finally, a PMS score was calculated in accordance with
techniques previously used (Rossignol & Bonnlander, 1990).
Those subjects identifyingthemselves as PMS sufferers on a
regular basis were evaluated.The individual symptom was
tallied as 1 for a reply of mild,2 for moderate, or 3 for
severe, for a potential maximum of 36.The actual numbers
for the combined group ranked from 0 to 32).This scoring
allowed for comparison of PMS symptomatology among the
study groups.21
Results
The general characteristics of each group of subjects
regularly suffering PMS are shown on Tables 1 and 2.The
median age of graduate students experiencing PMS regularly
was 31 years, the median age for the nursing students with
PMS was 31.5 years, and the group of patients for routine
medical exams were older, at a median age of 35 years.The
breast cancer patients were the oldest group with a median
age of 42 years.The graduate students had fewer term
pregnancies than the other three groups, with a median
number of 0.The nursing students, patients for routine
medical exams, and the breast cancer patient group had a
median number of 2 term pregnancies, whereas the breast
cancer patients had a median number of 1 term pregnancy.
Conversely, the graduate students presented the widest
range of overall PMS scores at a range of 3 to 32.The
other groups were 4 to 28 for student nurses,3 to 31 for
the routine exam patients, and 0 to 30 for the breast can-
cer patients.The graduates and cancer patients each
showed PMS symptom median scores of 11 points overall,
while the combined severity of student nurses and routine
exam patients ranked higher at, respectively, median scores
of 16 and 15.The most frequently reported PMS symptoms
are listed in Table 1.The complaint of irritability was
the most frequently reported general symptom.22
Table 1.General Characteristics of Subjects with PMS.
Subjects
with PMS Age (years)
Term Pregnancies
(number) PMS Score Symptom Frequency
Graduate
Students
(n=321)
Range = 24-52
(median = 31)
Age 40 or less = 85%
Age 30-50 = 58%
Range = 0-5
(median = 0)
One or more = 26%
Range = 3-32
(median = 11)
Irritability = 85%
Breast swelling &
tenderness = 85%
Bloating & weight
gain = 85%
Nursing
Students
(n=36)
Range = 24-45
(median = 31.5)
Age 40 or less = 92%
Age 30-50 = 56%
Range = 0-4
(median = 2)
One or more = 64%
Range = 4-28
(median = 16)
Irritability = 94%
Tiredness = 89%
Depression = 83%
Bloating & weight
gain = 83%
Routine
Exam
Patients
(n=156)
Range = 25-51
(median = 31.5)
Age 40 or less = 76%
Age 30-50 = 83%
Range = 0-5
(median = 2)
One or more = 81%
Range = 3-31
(median = 15)
Irritability = 93%
Bloating & weight
gain = 90%
Breast swelling &
tenderness = 83%
Breast
Cancer
Patients
(n=41)
Range = 32-46
(median = 42)
Age 40 or less = 29%
Age 30-50 = 100%
Range = 0-5
(median = 2)
One or more = 68%
Range = 0-5
(median = 11)
Irritability = 78%
Bloating & weight
gain = 90%
Binge eating = 63%
Breast swelling &
tenderness = 63%23
Table 2.General Characteristics of Subjects with PMS in
Relation to Severity.
Subjects
with PMS
Symptom Frequency by Severity
PMS Prior to
Menses
(average by
no. days)
Menstrual
Symptoms
(mild to severe) Mild Moderate Severe
Graduate
Students
(n=321)
Depression = 46%
Bloating & weight
gain = 44%
Acne = 44%
Tiredness = 44%
Breast swelling &
tendemess = 40%
Irritability = 39%
Bloating & weight
gain = 35%
Craving sweets
= 14%
Breast swelling &
tendemess = 11%
Irritability = 11%
Range = 0-14
(median = 7)
Symptoms
longer than 7
days = 25%
PMS yes = 94%
PMS no = 79%
Affected work:
PMS yes = 19%
PMS no = 12%
Nursing
Students
(n=36)
Bloating & weigh
gain = 47%
Acne = 47%
Depression = 39%
Irritability = 44%
Tiredness = 42%
Binge eating
= 39%
Irritability = 31%
Breast swelling &
tendemess = 22%
Tiredness = 19%
Craving sweets
=19%
Anxiety = 19%
Range = 2-12
(median = 7)
Symptoms
longer than 7
days = 39%
PMS yes
= 100%
PMS no = 87%
Affected work:
PMS yes = 28%
PMS no = 7%
Routine
Exam
Patients
(n=156)
Acne = 46%
Depression = 44%
Tiredness = 35%
Irritability = 42%
Anxiety = 38%
Tiredness = 37%
Craving sweets
= 24%
Irritability = 22%
Binge eating
=19%
Range = 0-16
(median = 7)
Symptoms
longer than 7
days = 37%
Range = 2-14
(median = 7)
Symptoms
longer than 7
days = 30%
PMS yes = 96%
PMS no = 81%
Affected work:
PMS yes = 22%
PMS no = 11%
PMS yes = 81%
PMS no = 85%
Affected work:
PMS yes = 27%
PMS no = 15%
Breast
Cancer
Patients
(n=41)
Bloating & weight
gain = 32%
Acne = 32%
Depression = 29%
Irritability = 34%
Headache = 34%
Breast swelling &
tendemess = 34%
Craving sweets
= 27%
Irritability = 24%
Tiredness =20%24
Table 2 lists the most commonly reported symptoms by
severity.The mild category indicated no single outstand-
ing symptom, but acne was in the top three listings for all
of the study groups.In the moderate column, irritability
frequently appeared in the first or second position.The
most frequent complaint in the severe category was either
irritability or craving sweets, both appearing as one the
three most commonly complained of symptoms for all four
study groups.The number of days PMS symptoms appeared on
average prior to the onset of menstruation is also indi-
cated in Table 2.The student nurse range was from 2 to 12
days, the graduate student range was 0 to 14 days, and the
cancer patient range was 2 to 14 days.The routine exam
patient range was the longest, at a maximum of 16 days
before menstruation onset each month.
The median number of seven days was consistent for all
four groups.However, the nurses experienced the greatest
number of days before menses onset, with 39 percent notic-
ing symptoms greater than the seven day median.The gradu-
ate student group results indicated that 25 percent experi-
enced symptoms earlier than seven days before menstruation
onset, whereas 37 percent of the routine exam patient group
and 30 percent of the breast cancer patient group experi-
enced PMS symptoms before the seven day median.The last
column in Table 2 shows the severity of menstrual symptoms
either with or without PMS, and the effect of these symp-
toms upon the work patterns of the subjects.Again, the25
nursing students ranked their menstrual severity the high-
est with for both conditions, whereas 85 percent of the
breast cancer patients experienced no PMS symptoms.How-
ever, at the same time the presence of menstrual symptoms
severe enough to affect their work was highest among the
breast cancer patients.
Examination of the crude exposure odds ratios for PMS
as a potential risk factor for breast cancer is listed in
Table 3.The graduate student group showed a crude expo-
sure odds rate of 2.2 (90% confidence level for 1.3 to
3.6), the nursing student group showed a crude exposure
odds ratio of 1.3 (90% confidence level for 0.6 to 2.7),
and patients seen for routine medical exams showed the
lowest crude ratio at 0.8(90% confidence interval for 0.4
to 1.4).
Table 3 also presents a control group stratification
by age groups.An increased exposure odds ratio for each
of the 41 to 50 years age level among the control groups,
compared to the 20 to 40 years category, was consistent
with an increased risk of breast cancer with increasing
age.As shown in Table 4,the breast cancer case group
showed that 76 percent of the sample population suffered
PMS regularly.The corresponding percentage for the con-
trol group of patients seen for routine medical exams was
higher at 81 percent of the sample population with PMS.
The graduate student group was ranked lowest at 57 percent,
with nursing students reported at 71 percent.26
Table 3.PMS Exposure Odds Risk for Breast Cancer.
Relative Risk (90% Confidence Interval)
Graduate Routine Exam
Nursing Students Students Patients
Crude Ratio 1.31 (0.63-2.73)2.20 (1.29-3.75)0.75 (0.41-1.37)
Ages 20-40 1.02 (0.38-2.74)1.71 (0.71-4.13)0.55 (0.22-1.40)
Ages 41-50+1.21 (0.16-9.24)2.19 (0.95-4.41)0.95 (0.87-1.04)
Pooled Ages 1.11 (0.99-1.12)1.90 (0.85-4.24)0.74 (0.45-1.22)
Pooled 1.39 (0.99-1.97)
Groups
Table 4.Frequency of PMS Symptomatology Among Study
Groups.
Description
Graduate
Students
(value/%)
Nursing
Students
(value/%)
Routine Exam
Patients
(value/%)
Breast
Cancer
Patients
(value/%)
PMS, Yes 321 @ 57 37 @ 71 156 @ 81 41 @ 76
PMS, No 224 @ 40 15 @ 29 37 @ 19 13 @ 24
Totals 559 @ 100 51 @ 100 193 @ 100 54 @ 100
Conclusions
The exposure odds ratio for graduate students over the
age of 41 years appeared to indicate an increased risk of
breast cancer with exposure to premenstrual syndrome, and a
slight preventive effect among the patients for routine
exams.However, considered jointly, the data do not sup-
port a risk of breast cancer in the presence of PMS.The
stratified age groups listed in Table 3, specifically the
relatively wide confidence intervals, suggest that the
sample size for the breast cancer group was not suffi-
ciently large to precisely estimate relatively minor in-
crease factors.Some confounding by age was evident when
the crude exposure odds ratio was compared to the pooled27
exposure odds rate within each control group.However, the
age-stratified odds ratio for each group showed little
effect modification by age.For example, the nursing stu-
dents control group crude exposure odds ratio of 1.3, com-
pared to the pooled age category of 1.1, indicates slight
confounding by age.However, the age-stratified groups of
1.0 for the 20 to 40 years level and 1.2 for the 41 to 50
years level indicated little modification by age.The wide
confidence intervals (0.16-9.24) for the 41 to 50 years age
group, for example, suggested a random error, probably due
to the small sample size.
The graduate student group was larger (n=559), a fac-
tor which contributed to a narrower confidence interval for
the crude exposure odds rate of 2.2 (90% confidence inter-
val for 1.3-3.8).However, the confidence level increased
when the graduate student group was stratified by age and
then pooled, as shown in Table 3.
The control group most similar to the breast cancer
cases were patients seen for routine medical exams.The
median age of this control group was 36 years, compared to
a median age of 42 years for the breast cancer group.A
large sample size (n=193) for the routine medical exam
patient control group allowed a comparison ratio of 3.6:1.0
to the breast cancer patient group (Table 2).The exposure
odds ratios for the routine medical exam patient group were
similar to the crude exposure odds ratios and the pooled
odds ratio provided little indication of confounding by28
age.The age-stratified figures also indicated there was
no effect modification.A crude OR of 0.8 (90% confidence
interval for 0.4 to 1.4) and the pooled OR for the two age
groups of 0.7 (90% confidence interval for 0.5 to 1.2)
appeared to show a slight indication of preventive effect,
but could also be reasonably be explained by random vari-
ation.
The self-ranking method used for this type of survey
contains a potential bias since pain perception among the
subjects may not be consistent since pain threshold toler-
ance is individual in nature.Increased physical awareness
among the breast cancer patients may heighten the need to
take better care of themselves, influencing how they re-
spond to PMS and to menstrual symptoms with respect to
daily activities.Patients surviving a life-threatening
disease such as breast cancer may differ in perspective
with regard to PMS symptoms and their physical well-being
when compared to the control group subjects.
A possible source of error could be attributed to the
brief description of PMS in the questionnaire.It may be
speculated that subjects perhaps misunderstood the differ-
ences between PMS and menstrual symptoms.To control for
recall bias among the breast cancer patients, only recently
diagnosed patients were eligible, and those reporting on
their patterns prior to diagnosis were screened for recent
histories.As reported above, three women reported on
their PMS patterns before undergoing complete hysterecto-29
mies, but the surveys were discarded due to the length of
post-operative time which had passed.
Another potential error deals with certain drug thera-
pies for breast cancer, which can suppress ovarian func-
tion.Although the question was asked whether the patient
was taking any drugs, nothing was asked of past drug his-
tory.Two cancer patients reported ovarian suppression
causing a cessation of menstruation, yet listed PMS symp-
toms.Since the exposure odd ratios among the different
control groups were within such close range, bias and con-
founding appeared to be minimal.
The power of this study and its variability presented
problems due to the small sample population size of pre-
menopausal breast cancer cases.A larger sample population
may be indicated to determine if there is a relationship
between PMS and breast cancer, especially given the lack of
documented evidence in this area of inquiry.30
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AbstractThis study found substantial differences among obstetricians and gynecol-
ogists in their beliefs about the etiology of and preferred modes of treatment for
premenstrual symptoms.
premenstrual syndrome (PMS) is an array of symptoms that occurs or
is aggravated during the late luteal phase of the menstrual cycle. The
symptoms typically include depression, anxiety, irritability, breast
swelling and tenderness, water retention, headaches, and food crav-
ings, although well over 100 symptoms have been reported to be associated
with the premenstrual phase of the menstrual cycle.' Several investigators
have reported that the term "premenstrual syndrome" is a misnomer in that
the "syndrome" in fact is comprised of several distinct syndromes, some of
which consist primarily of physical ailments whereas others consist of emo-
tional or psychological symptoms; other investigators find no reproducible
subclassifications of [WS.'
Putative causes of PMS include a wide variety of psychological, biochem-
ical, and lifestyle factors, including a deficiency of progesterone and an excess
of estrogen; deficiencies in prostaglandins, vitamins (especially vitamin 8,
deficiency), and/or magnesium; hypoglycemia; fluid retention; an excess of
prolactin; an allergy to one's own hormones; endorphin deficiency or abnor-
mality; stress; psychiatric disorder; lack of exercise; caffeine; high sodium
intake; alcoholic beverage use; a diet high in sugar and refined sugar; and
variation in daily hours of sunlight (PN1S and seasonal affective disorder have
0 1992 by The Jacobs Inatome of
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35been reported to be related)." Few conclusive data exist, however, to support
a causal role for any of these factors. The data that do exist tend to come
from small case studies (fewer than 30 subjects) with attendant problems of
lack of precision and statistical power."
Given the lack of consistency in the PMS literature, it seems possible that
substantial variability in beliefs about EMS and preferred modes of treatment
for women diagnosed as having PMS might exist among practicing obstetri-
cians and gynecologists." The objective of this study was to assess the extent
of any such variability, with particular emphasis on whether differences in
beliefs or preferred modes of treatment vary according to the age or sex of
practicing obstetricians and gynecologists.
METHODS
The study was conducted in the state of Oregon. Eligible physicians were the
351 physicians registered by the Oregon Board of Medical Examiners as cer-
tified to specialize in obstetrics and/or gynecology in Oregon.
Each eligible physician was mailed a questionnaire soliciting information
about medical practices concerning PMS and about the physician's assessment
of the major precipitating factors for PMS onset. Physicians were asked to
rank the top five in a list of 13 putative precipitating factors for PMS onset
(age, caffeine, childbirth, depression, sugar intake, sodium intake, hormonal
imbalance, lack of exercise, low pain threshold, psychological difficulties,
variation in hours of sunlight, self-preoccupation, and stress) and to check
as many of the preferred modes of treatment as were relevant. To reduce the
likelihood that the physicians would suspect our interest in comparing re-
sponses according to age and sex, information about the age and sex of each
physician was ascertained from a listing provided by the Oregon Board of
Medical Examiners.
Two hundred thirty (66%) of the physicians returned questionnaires after
two mailings. Six of the respondents subsequently were found not to be
certified to specialize in obstetrics and/or gynecology in Oregon and were
excluded from the data analysis. This exclusion left data on 224 obstetrician
and/or gynecologist specialists for analysis. The questionnaires for 12 of these
224 respondents had missing information; these questionnaires were included
in the data analysis for questions for which answers were available. The study
physicians ranged in age from 28 to 86 years. Twenty-seven percent of the
physicians were women.
The data were analyzed by sex and by two age categories (less than 40
years old and age 40 years or older). The age categories were determined
partly on the basis of observed differences in responses according to these
age categories, and partly by a need to have enough respondents in each
group to yield stable estimates.
RESULTS
Forty-eight percent of the 224 physicians reported that his/her office's medical
questionnaire, filled out on a patient's first visit, contained questions specific
to the symptoms of PMS. The percentage ranged from 41% for female phy-
sicians who were less than 40 years of age to 50% for male physicians aged
40 years or older.
Ninety percent of the 67 physicians under the age of 40 years and 78%
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36Differences among preferred modes of treatment were observed accord-
ing to the physician's age and sex, but were not substantial (Table 2). Part of
those differences observed were attributable to an overall increase in the
numbers of treatment approaches used by younger physicians as compared
with older physicians.
DISCUSSION
The study results indicate that the major precipitating factor for PMS onset
having the highest overall level of agreement was stress, which was scored
by 63% of the study physicians. The most common mode of treatment for
mild, moderate, and severe PMS was exercise, mentioned by 77, 72, and 57%
of the study physicians, respectively.
The results of this study also indicate that substantial differences exist
among obstetricians and/or gynecologists in their beliefs about PMS and in
their preferred modes of treatment for women diagnosed as having PMS. In
addition, some of these beliefs and preferred modes of treatment vary ac-
cording to the physician's age and, particularly among young physicians,
according to sex. Differences by age might result from beliefs or practices
garnered from years of medical experience and/or proximity to medical school
education.
It is interesting to note that nutritional approaches were mentioned as
one of the leading modes of treatment for mild, moderate, and severe PMS
(mentioned by 68, 58, and 48% of physicians, respectively), although the
three components of diet queried as major precipitating factors for PMS onset
were mentioned by only 17-25% of physicians. In addition, exercise was
ranked as the leading preferred mode of treatment for mild, moderate, and
severe PMS (mentioned by 77, 72, and 57% of the physicians, respectively),
although lack of exercise was mentioned as a major precipitating factor for
PMS onset by only 47% of physicians. Progesterone (suppositories or oral
doses) was used by 45% of the physicians, although its effectiveness has been
questioned.
Three possible sources of error warrant discussion. The first possible
source of error pertains to our using a self-administered questionnaire to
collect information about medical practices rather than using a more direct
assessment of actual practice (reviewing medical records, for example). It is
possible that some physicians reported practices that differ from their actual
practices.
The second possible source of error pertains to limitations inherent in
assessing "usual" medical care. Several physicians commented that their pre-
ferred modes of treatment for women with PMS depended on the specific
PMS symptoms present rather than on an overall assessment of the severity
of symptoms. For this reason, it may have been difficult for some physicians
to report their "preferred" modes of treatment.
The third possible source of error is differences in the physicians' inter-
pretations of the structured answers provided on the questionnaire. For ex-
ample, "age- related," "depression," and "psychological difficulties," each listed
as possible major precipitating factors for PMS onset, may have been inter-
preted differently by different physicians.
These possible sources of error notwithstanding, the results of this study
document the considerable variability in beliefs about PMS onset and treat-
ment approaches among obstetncians and gynecologists, and suggest the
clear need for controlled trials evaluating the effectiveness of the various
treatment modalities.
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Appendix B
Women's Health Survey40
WOMEN'S HEALTH SURVEY
GENERAL INFORMATION
Please leave blank.
1.Whatisyour age? /_/ / 4,5
2.Whatisyour height? /__/__/ 6,7
3.Whatisyour weight? / _J_/_/ 8-10
4.Whatisthe reason for your visit? /_J 11
PREMENSTRUAL AND MENSTRUAL HEALTH
5.Do you experience premenstrual syndrome?No Yes
(Premenstrual syndrome is an array of symptoms
beginning approximately one week prior to each // 12
menstrual period and usually ending a couple of
days prior to your period.Premenstrual syndrome
is different from menstrual symptoms, which occur
at the time of your period.Many of the most common
symptoms of premenstrual syndrome are listed in
question 6.)
6.If you do experience premenstrual syndrome,circle the
experience.
11.)
/
/
/
/
13
14
severity of each the following symptoms you
(If you do not experience premenstrual symptoms
on a regular basis each month, skip to question
Depression MildModerateSevere
Tiredness MildModerateSevere
Irritability MildModerateSevere //15
Anxiety MildModerateSevere //16
Bloating and weight gain MildModerateSevere//17
Headaches MildModerate Severe //18
Breast swelling, tenderness MildModSevere//19
Craving for sweet foods MildModerateSevere//20
Craving for salty foods MildModerateSevere//21
Binge eating MildModerateSevere //22
Skin acne MildModerateSevere //23
Other (please specify) MildModSev//2441
Please leave blank.
7.About how many days before your menstrual
period do the premenstrual symptoms circled
in question 6 occur? /__/ 25
8.Would you say that your premenstrual symptoms
(described in question 6) overallare mild,
moderate, or severe? /__/ 26
9.Are your premenstrual symptoms severe enough to
cause you to miss work or interfere with your
daily housework? No Yes /_J 27
10. Are your premenstrual symptoms severe enough to
cause you to take aspirin or other medications?
No Yes /__/ 28
11. Does (did) your mother experience premenstrual
syndrome? No Yes Unknown // 29
12. Does your sister(s) experience premenstrual
syndrome? No Yes Unknown No sisters // 30
13, Circle the severity of the following menstrual symptoms
which you regularly experience at the time ofyour period.
Cramps MildModerateSevere /__/ 31
Headache MildModerateSevere // 32
Tiredness MildModerateSevere // 33
Other (please specify) MildModSev // 34
Do not experience discomfort or any of the above
symptoms during menstrual period (skip to
question 16) /__/ 35
14. Would you say that your menstrual symptoms
(described in question 12) overall are mild,
moderate, or severe? /__/ 36
15. Are your menstrual symptoms severe enough to cause
you to miss work or interfere with your daily
housework?No Yes /__/ 37
16. Have you ever been told by a doctor that you have
endometriosis? No Yes // 38
17. Have you used oral contraceptives (birth control
pills) within the past three months? No Yes // 3942
Please leave blank.
18. How many full-term pregnancies have you had? /__/ 40
19. Which, if any, of the following procedures have you had?
Tied tubes Ovaries removed None /_J 41
Hysterectomy Other (please specify)
DIETARY HABITS
20. Are you taking any medications?Yes No If yes,
list all medications you currently take, including any
vitamins. /__/ 42
21. About how many times during a typical day do you
eat "sweets" or junk food? // 43
22. How many of the "sweets" or junk food consumed during a
typical day (question 21) contain chocolate? // 44
23. About how many cups of each of the following beverages
do you drink during a typical day?(One "cup" is equal
to about eight ounces, or one measuring cupful.)
Water /__/ 45
Fruit juice /__/ 46
Milk /__/ 47
Caffeine-free soft drink /_J 48
Caffeine-containing soft drink /__/ 49
Hot chocolate // 50
Decaffeinated coffee /__/ 51
Caffeine-containing coffee /__/ 52
Herbal tea (non-caffeine-containing tea) // 53
Caffeine-containing tea /__/ 54
Milk shake, ice cream soda /_J 55
Other beverages (note that alcoholic drinks are
listed in question 24) /__/ 5643
Please leave blank.
24. About how many drinks of each of the following
beverages do you consume during a typical week?
Beer (one can) // 57
Wine (six ounces) /__/ 58
Hard liquor (one ounce) /__/ 59
25. Would you be willing to be interviewed in person /_J 60
to provide more detailed information about your
premenstrual and menstrual health, and about your
dietary habits?No Yes If yes, please provide
your name, address, and/or telephone number.
THANK YOU VERY MUCH FOR PARTICIPATING IN
THE WOMEN'S HEALTH SURVEY